Skip to content
Home/Companies/MedTech/MintNeuro

MintNeuro

MedTech·UK·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns MintNeuro?

MintNeuro is currently owned by Parkwalk Advisors through Parkwalk Opportunities EIS Fund (2009 vintage), since 2024.

Hand-verified · updated 2026-07-31

Parkwalk Advisors
Investor
Parkwalk Advisors
Parkwalk Opportunities EIS Fund · 2009 · VC

Key facts

HQUK
SectorMedTech
StatusActive

More from Parkwalk Opportunities EIS Fund

Other portfolio companies in the same fund.

1715 Labs
Exited 2023
AI/MLUK
ACAL Energy
Exited 2017
EnergyUK
Aqdot
Aqdot
Active
Deep TechUK
Arkivum
Arkivum
Active
SoftwareUK
Arvia
Arvia
Active
ClimateTechUK
Cytotrait
Active
BiotechUnited Kingdom· 2026

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Optos
Exited 2015
Amadeus Capital PartnersUK
to
Axomove
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Clee Medical
Clee Medical
Active
High-Tech Gruenderfonds (HTGF)Switzerland· 2026
CollimateHealth
Active
Caesar Ventures ManagementGermany· 2026
Track MintNeuro

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on MintNeuro.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue